2Ashbaugh DG;Bigelow DB;Petty L.Acute respiratory ditress in adults[J],1967.
3Bernard GR;Artigas A;Brigham KL.and the consensus committee The American-European Consensus Conference on ARDS,definitions,mechanisms,relevant outcomes,and clinical trial coordination,1994.
4Artigas A;Bernard GR;Carlet J.The American-European Consensus Conference on ARDS,part2:ventilatory,pharmacologic,supportive therapy,study design strategies,and issues related to recovery and remodeling,1998.
5National Heart and Lung Institute.Task force on problems,resesrch approaches,needs:the lung program,Washington,DC:Department of health,education,and welfare,1972.
6Luhr OR;Antonsen K;Karlsson M.and the ARF study group Incidence and mortality after acute respiratory failure and acute respiratory dirtress syndrome in Sweden,Denmark,1999.
7Jerng JS;Yu CJ;Liaw YS.Clinical spectrum of acute resperatory distress syndrome in a tertiary referral hospital:etiology,severity,clinical course,and hospital outcome,2000.
8Brun-Brisson C;Minelli C;Brazzi L.The European survey(alive)of acute lung injury and ARDS,2001.
9Lewandowski K;Rossaint R;Pappert D.High survival rate in 122 ARDS patients managed according to a clinical algorithm including extracorporeal membrane oxygenation[J],1997.
10Lundin S;Mang H;Smithies M.Inhalation of nitric oxide in acuet lung injury:results of a European multicentre study[J],1999(9).
6Winker R,Schaffer A W,Konnaris C, et al. Health consequences of an intravenous injection of metallic mercury[J]. Int Arch OccupEnviron Health,2002,75(8) :581--586.
7Nalepa P, Lech T,Kotucha W. Intravenous injection of metallic mercury casereport[J].Pneumonol Alergol Po1,1996,64(1/ 2) -88--92.
